Breaking News Instant updates and real-time market news.

HSDT

Helius Medical

$9.40

-0.4 (-4.08%)

, PDVW

pdvWireless

$33.93

0.03 (0.09%)

04:55
10/02/18
10/02
04:55
10/02/18
04:55

PubCoCEO to hold a conference

MicroCap Conference 2018 will be held in New York on October 1-2.

HSDT

Helius Medical

$9.40

-0.4 (-4.08%)

PDVW

pdvWireless

$33.93

0.03 (0.09%)

ADIL

Adial Pharmaceuticals

$2.76

-0.24 (-8.00%)

NAKD

Naked Brand Group

$2.41

-0.29 (-10.74%)

OGEN

Oragenics

$1.60

0.46 (40.35%)

CURR

CURE Pharmaceutical

$0.00

(0.00%)

JTPY

JetPay

$2.10

0.1 (5.00%)

ISDR

Issuer Direct

$15.31

-0.64 (-4.01%)

INPX

Inpixon

$0.21

0.0031 (1.54%)

XXII

22nd Century

$2.78

-0.03 (-1.07%)

PRLX

Parlex Corp.

$0.00

(0.00%)

KMDA

Kamada

$6.22

0.065 (1.06%)

LMAT

LeMaitre

$37.24

-1.48 (-3.82%)

DXR

Daxor

$5.44

0.18 (3.42%)

SNOA

Sonoma Pharmaceuticals

$1.54

(0.00%)

  • 02

    Oct

  • 04

    Oct

  • 04

    Oct

  • 05

    Oct

HSDT Helius Medical
$9.40

-0.4 (-4.08%)

06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral from Buy at BTIG
06/19/18
BTIG
06/19/18
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral at BTIG on delay in PNS clearance
As reported, BTIG analyst Sean Lavin downgraded Helius Medical to Neutral from Buy citing yesterday's announced delay in filing for the FDA clearance of its Portable Neuromodulation Stimulator investigational medical device in Q3 rather than Q2. The analyst notes that the delay raises the risk of the company running out of cash before clearance and may force it to raise more capital, putting the spotlight on the management's credibility. Lavin adds that given the rise in the stock price to his prior target of $14, a Neutral rating is "more appropriate".
05/17/18
05/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Buy at Loop Capital. 2. Align Technology (ALGN) initiated with an Outperform at Evercore ISI. 3. Baxter (BAX) assumed with an Overweight at Piper Jaffray. 4. Comtech (CMTL) initiated with a Neutral at Citi. 5. Helius Medical (HSDT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/17/18
BTIG
05/17/18
INITIATION
Target $14
BTIG
Buy
Helius Medical initiated with a Buy at BTIG
BTIG analyst Sean Lavin initiated Helius Medical with a Buy rating and a price target of $14, saying the company's offerings have the "potential to help people with traumatic brain injuries to regain normal function, balance, and the ability to walk." Lavin adds that Helius Medical's Portable Neuromodulation Stimulator is shown to produce "significant improvement in balance and function" in patients, who have "no other good options", expecting the company to target workers' comp, the military, and normal medical insurers. He also expects the investment story to result in positive public sentiment, driving adoption and reimbursement. The analyst does note some risks for the company, including its recently missed primary efficacy endpoint. which could prompt the FDA to ask for more data. as well as the company's impending capital needs.
PDVW pdvWireless
$33.93

0.03 (0.09%)

ADIL Adial Pharmaceuticals
$2.76

-0.24 (-8.00%)

10/01/18
DAWS
10/01/18
INITIATION
Target $6
DAWS
Adial Pharmaceuticals at Dawson James
Dawson James initiated Adial Pharmaceuticals with a Buy and $6 price target.
NAKD Naked Brand Group
$2.41

-0.29 (-10.74%)

OGEN Oragenics
$1.60

0.46 (40.35%)

CURR CURE Pharmaceutical
$0.00

(0.00%)

JTPY JetPay
$2.10

0.1 (5.00%)

04/25/18
BRRR
04/25/18
INITIATION
Target $3
BRRR
Outperform
JetPay initiated with an Outperform at Barrington
Barrington analyst Gary Prestopino started JetPay with an Outperform rating and $3 price target.
ISDR Issuer Direct
$15.31

-0.64 (-4.01%)

09/07/18
NORL
09/07/18
INITIATION
Target $21
NORL
Outperform
Issuer Direct initiated with an Outperform at Northland
Northland analyst Mike Grondahl initiated Issuer Direct with an Outperform and $21 price target saying it has developed into a leader in disclosure management, communications and compliance services for both public and private companies.
INPX Inpixon
$0.21

0.0031 (1.54%)

XXII 22nd Century
$2.78

-0.03 (-1.07%)

PRLX Parlex Corp.
$0.00

(0.00%)

KMDA Kamada
$6.22

0.065 (1.06%)

02/02/18
CHDN
02/02/18
INITIATION
Target $7
CHDN
Buy
Kamada initiated with a Buy at Chardan
Chardan analyst Keay Nakae initiated Kamada with a Buy and $7 price target.
LMAT LeMaitre
$37.24

-1.48 (-3.82%)

06/08/18
06/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pfizer (PFE) and Eli Lilly (LLY) were initiated with an Overweight at Cantor Fitzgerald. 2. LivaNova (LIVN) initiated with a Buy at Stifel. 3. Occidental Petroleum (OXY) and Chevron (CVX) were initiated with a Buy at Mizuho while ConocoPhillips (COP) and Exxon Mobil (XOM) were initiated with a Neutral. 4. LeMaitre (LMAT) resumed with a Buy at Roth Capital. 5. Savara (SVRA) initiated with an Outperform, sees 300% upside, says Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/18
04/26/18
UPGRADE
Target $40

Buy
LeMaitre upgraded to Buy amid 'excessive' selloff at Benchmark
As previously reported, Benchmark analyst Raymond Myers upgraded LeMaitre Vascular to Buy from Hold as he believes the 20% post-earnings selloff in the shares is "excessive." He attributes the Q1 earnings shortfall mainly to sales execution issues and thinks management has already taken the necessary steps to fix the problems, he tells investors. Myers, who sees plans to expand the sales force leading to accelerating revenue growth in 2019, set a $40 price target on LeMaitre shares.
06/25/18
LSCM
06/25/18
INITIATION
Target $45
LSCM
Buy
LeMaitre initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil initiated LeMaitre Vascular with a Buy rating and $45 price target, contending that its recent biologics-focused acquisitions give it rapidly growing niche products that its sales organization can cross-sell to its installed base of vascular surgeons to expand its "already successful business."
06/08/18
ROTH
06/08/18
INITIATION
Target $38
ROTH
Buy
LeMaitre resumed with a Buy at Roth Capital
Roth Capital analyst Scott Henry resumed coverage of LeMaitre Vascular with a Buy rating and $38 price target, as he expects resumed sales-force expansion to drive organic growth in the near-term and thinks the company's Reddick divestiture could help fund an acquisition, which could be a catalyst.
DXR Daxor
$5.44

0.18 (3.42%)

SNOA Sonoma Pharmaceuticals
$1.54

(0.00%)

03/05/18
MAXM
03/05/18
DOWNGRADE
MAXM
Hold
Sonoma Pharmaceuticals downgraded to Hold from Buy at Maxim
03/05/18
03/05/18
DOWNGRADE

Hold
Sonoma Pharmaceuticals downgraded to Hold after capital raise at Maxim
As previously reported, Maxim analyst Jason Kolbert downgraded Sonoma Pharmaceuticals to Hold from Buy after the company raised capital by selling shares in secondary offering that priced at $3.50 per share. After adjusting his model for the new share count he believes that there is only modest upside in the stock at current levels, said Kolbert, who sees catalysts as lacking over the next 12 months.
07/20/18
07/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. OneMain Holdings (OMF) reinstated with an Equal Weight at Barclays. 2. Viking Therapeutics (VKTX) initiated with a Buy at SunTrust. 3. Semtech (SMTC) initiated with a Buy at Stifel. 4. Axon (AAXN) initiated with a Buy at Needham. 5. Sonoma Pharmaceuticals (SNOA) assumed with a Speculative Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/18
BNCH
07/20/18
INITIATION
Target $3
BNCH
Speculative Buy
Sonoma Pharmaceuticals assumed with a Speculative Buy at Benchmark
Benchmark analyst Bruce Jackson assumed coverage of Sonoma Pharmaceuticals with a Speculative Buy rating and $3 price target, stating that he sees execution risk as the company pivots to a more profitable revenue model but that a higher multiple is possible if Sonoma can improve its cash flow and margins.

TODAY'S FREE FLY STORIES

SUI

Sun Communities

$99.13

(0.00%)

, UMH

UMH Properties

$14.81

(0.00%)

09:40
10/18/18
10/18
09:40
10/18/18
09:40
Hot Stocks
Sun, UMH part of New York AG settlement over rent-to-own practices »

New York Attorney General…

SUI

Sun Communities

$99.13

(0.00%)

UMH

UMH Properties

$14.81

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 02

    Nov

PTI

Proteostasis

$1.89

(0.00%)

, NOK

Nokia

$5.52

(0.00%)

09:40
10/18/18
10/18
09:40
10/18/18
09:40
Options
Unusually active option classes on open October 18th »

Unusual total active…

PTI

Proteostasis

$1.89

(0.00%)

NOK

Nokia

$5.52

(0.00%)

CCK

Crown Holdings

$47.64

(0.00%)

AA

Alcoa

$36.71

(0.00%)

CZR

Caesars

$10.19

(0.00%)

HD

Home Depot

$185.10

(0.00%)

ATVI

Activision Blizzard

$78.25

(0.00%)

UNG

United States Natural Gas Fund

$27.45

(0.00%)

BMY

Bristol-Myers

$58.91

(0.00%)

PM

Philip Morris

$84.62

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

CMG

Chipotle

$429.63

-4.44 (-1.02%)

09:38
10/18/18
10/18
09:38
10/18/18
09:38
Recommendations
Chipotle analyst commentary  »

Chipotle Q3 sales likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$36.00

-0.135 (-0.37%)

09:37
10/18/18
10/18
09:37
10/18/18
09:37
Hot Stocks
Terreno Realty acquires building in Carlstadt, NJ for $3.5M »

Terreno Realty acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MERC

Mercer

$16.90

-0.54 (-3.10%)

09:36
10/18/18
10/18
09:36
10/18/18
09:36
Upgrade
Mercer rating change  »

Mercer upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

09:35
10/18/18
10/18
09:35
10/18/18
09:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

TXT

Textron

$64.72

-2.01 (-3.01%)

09:32
10/18/18
10/18
09:32
10/18/18
09:32
Technical Analysis
Technical Take: Textron tumbles after results »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

MET

MetLife

$44.66

0.81 (1.85%)

09:32
10/18/18
10/18
09:32
10/18/18
09:32
Hot Stocks
MetLife names Tim Ring chief sustainability officer »

MetLife announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 14

    Nov

ACHC

Acadia

$35.77

0.28 (0.79%)

, KKR

KKR

$25.56

-0.09 (-0.35%)

09:31
10/18/18
10/18
09:31
10/18/18
09:31
Recommendations
Acadia, KKR analyst commentary  »

Acadia may receive 11-12…

ACHC

Acadia

$35.77

0.28 (0.79%)

KKR

KKR

$25.56

-0.09 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

CHA

China Telecom

09:31
10/18/18
10/18
09:31
10/18/18
09:31
Downgrade
China Telecom rating change  »

China Telecom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHU

China Unicom

$11.34

-0.055 (-0.48%)

09:31
10/18/18
10/18
09:31
10/18/18
09:31
Downgrade
China Unicom rating change  »

China Unicom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$267.23

-5.01 (-1.84%)

09:31
10/18/18
10/18
09:31
10/18/18
09:31
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$78.25

-0.48 (-0.61%)

09:29
10/18/18
10/18
09:29
10/18/18
09:29
Recommendations
Activision Blizzard analyst commentary  »

Baird says 'Call of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VJET

voxeljet

$2.69

-0.265 (-8.97%)

09:28
10/18/18
10/18
09:28
10/18/18
09:28
Syndicate
voxeljet 4.86M share Secondary priced at $2.57 »

Piper Jaffray acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

STMP

Stamps.com

$203.59

-19.79 (-8.86%)

09:26
10/18/18
10/18
09:26
10/18/18
09:26
Recommendations
Stamps.com analyst commentary  »

Stamps.com selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$36.71

0.51 (1.41%)

09:25
10/18/18
10/18
09:25
10/18/18
09:25
Recommendations
Alcoa analyst commentary  »

Alcoa remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$9.39

-0.35 (-3.59%)

09:25
10/18/18
10/18
09:25
10/18/18
09:25
Conference/Events
Earthstone Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$0.92

0.0007 (0.08%)

09:25
10/18/18
10/18
09:25
10/18/18
09:25
Initiation
Eldorado Gold initiated  »

Eldorado Gold initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BTI

British American Tobacco

$43.09

1.18 (2.82%)

09:24
10/18/18
10/18
09:24
10/18/18
09:24
Downgrade
British American Tobacco rating change  »

British American Tobacco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRFHF

Fairfax Financial

$0.00

(0.00%)

09:23
10/18/18
10/18
09:23
10/18/18
09:23
Upgrade
Fairfax Financial rating change  »

Fairfax Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMS

Fresenius Medical

$41.49

-8.37 (-16.79%)

09:22
10/18/18
10/18
09:22
10/18/18
09:22
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$28.70

-0.01 (-0.03%)

09:21
10/18/18
10/18
09:21
10/18/18
09:21
Conference/Events
Deciphera has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 24

    Oct

  • 27

    Nov

BMTC

Bryn Mawr Bank

$44.65

0.15 (0.34%)

09:18
10/18/18
10/18
09:18
10/18/18
09:18
Earnings
Bryn Mawr Bank reports Q3 adj. EPS 84c, consensus 82c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/18/18
10/18
09:18
10/18/18
09:18
Options
Overnight activity included 195 trades in SPX and 9 trades in VIX »

195 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRB

American River

$15.20

(0.00%)

09:17
10/18/18
10/18
09:17
10/18/18
09:17
Earnings
American River reports Q3 EPS 20c, consensus 22c »

During the third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.